LBCA Scientific Advisory Board Chair, Dr. Mouabbi Presents ILC Research Poster At ASCO.
Published on June 25, 2024
“LBCA Scientific Advisory Board Chair, Dr. Jason Mouabbi recently presented a research poster on invasive lobular carcinoma (ILC) at the American Society of Clinical Oncology (ASCO) annual meeting that was held May 30- June 3rd in Chicago. The ASCO event is considered one of the most significant gatherings of oncology professionals in the world. During the event, poster presentations are given as a tool to present new information in a graphic form. The posters are… read more
I agree Barb- sometimes the hoops we have to jump through to get to the newest treatments is insane! Immunotherapy above chemotherapy therapy will make these treatments so much less painful for those who come after us.
Good to know they are doing more and more research on Immunotherapy and using it with chemo.... let's just hope insurances get up to speed and make it easier for cancer patients to have access to the latest and greatest treatments. B
@A MyBCTeam Member
Yes, I looked at the poster online.
Very complicated information.
Dr. Mouabbi has dedicated his life to working with ILC and finding cures.
Wow, that is very interesting although very scientific! I’m happy to hear that this oncologist is finding helpful information for those with ILC. Thanks for sharing!
Donna not intended to be scary but to keep us aware so that we ask all the questions floating around in our heads. I am walking that path right now.
Lobular Breast Cancer Comes Into The Research Spotlight. My
Trying To Decide Lumpectomy Vs Mastectomy
Has Anyone Done 12 Weekly Infusions Of Taxol And Lost Their Hair?